Indraprastha Medical Corporation P/E Ratio
Current P/E Ratio
17.93
Moderate Valuation
Moderate - Fairly valued
Indraprastha Medical Corporation (INDRAMEDCO) P/E ratio is 17.93 (Moderate), EPS (TTM) ₹20.03, current price ₹391.80 on NSE — Moderate - Fairly valued. Browse INDRAMEDCO income statement for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
17.93
Current Price
₹391.80
EPS (TTM)
₹20.03
Exchange
NSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
68.37
Sector Median
45.42
Sector Rank
#9 of 56
Sector Percentile
16.1%
INDRAMEDCO P/E Ratio — Valuation Signal & Historical Context
Indraprastha Medical Corporation P/E 17.93 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see INDRAMEDCO stock price BSE.
- Trading at discount to sector average PE of 68.37
INDRAMEDCO vs Healthcare Services Peers — P/E Ratio Comparison
Indraprastha Medical Corporation P/E 17.93 vs Healthcare Services average 68.37, median 45.42 — range 7.98–460.81.
Sector Average
68.37
Sector Median
45.42
Lowest P/E
7.98
Highest P/E
460.81
Companies
56
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.98 | ₹125 | Low |
| Shanmuga Hospital | SHANMUGA | 12.91 | ₹54 | Low |
| Nidan Labs & Healthcare | NIDAN | 13.47 | ₹20 | Low |
| Deccan Health Care | DECCAN | 14.18 | ₹32 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.84 | ₹920 | Low |
| Abate AS Industries | ABATEAS | 14.93 | ₹162 | Low |
| Invicta Diagnostic | INVICTA | 17.24 | ₹80 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.7 | ₹1,061 | Moderate |
| Dr Lalchandani Labs | DLCL | 19.85 | ₹8 | Moderate |
| Chandan Healthcare | CHANDAN | 20.22 | ₹572 | Moderate |